STVN Stock — Stevanato Group SpA

Stevanato Group SpA (STVN)

Updated October 16, 2026.

STVN is a Stock. its distribution rate is 0.33%, its trailing-12-month yield is 0.33%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is -2.5% over the past 5.3 years, 92.3 points behind SPY at 89.8%.

Stevanato Group is an Italian manufacturer of pharmaceutical packaging and drug delivery solutions, including pre-fillable syringes, vials, cartridges, and injectable devices, along with diagnostic equipment and contract manufacturing services for the biopharma and healthcare industries. The stock has a very modest current distribution rate and pays distributions annually. This company appeals primarily to growth-oriented investors seeking exposure to the healthcare and pharmaceutical manufacturing sector, with income as a secondary consideration.

STVN performance versus SPY

Price and return data through 2026-10-16.

Total return is -2.5% over the past 5.3 years, 92.3 points behind SPY at 89.8%. Over the past year its total return — price change plus distributions reinvested — is -21.3%. Its deepest 1-year drawdown was 51.4%.

STVN key facts

Distribution Safety Score™

50 · Unproven

Asset type

Stock

Asset class

Equity

Inception date

07/16/2021

Distribution rate

0.33%

Distribution frequency

Annual

Trailing yield

0.33%

5-year average yield

0.26

Last close

$18.90 (as of 2026-10-16)

Market cap

$941,828,599

Average volume

277778.0

Dividend

$0.062

Ex-dividend date

06/11/2026

Payment date

07/29/2026

Beta

0.778

Payout ratio

9.4%

P/E ratio

33.16

Forward P/E

29.1545

EPS

$0.57

How Dividend Vision calculates yield and returns

Distribution rate (0.33%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.33%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

STVN risks and drawbacks

STVN's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are annual, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 51.4%.

Who may consider STVN — and who may not

It is a weaker fit for investors who need monthly cash flow (STVN pays annual); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on STVN

• All tickers starting with S

Tagged: Healthcare, Dividend.

Frequently asked questions